C1 inhibitor deficiency: consensus document (Q24684165)

Europe PubMed Central

title

C1 inhibitor deficiency: consensus document (English)

0 references

main subject

C1 inhibitor deficiency

1 reference

M M Gompels

1

0 references

R J Lock

2

0 references

M Abinun

3

0 references

C A Bethune

4

0 references

G Davies

5

0 references

C Grattan

6

0 references

A C Fay

7

0 references

H J Longhurst

8

0 references

L Morrison

9

0 references

A Price

10

0 references

M Price

11

0 references

D Watters

Clinical and Experimental Immunology

12

0 references

language of work or name

English

0 references

publication date

March 2005

0 references

published in

0 references

volume

139

0 references

issue

3

0 references

page(s)

379-94

0 references

cites work

Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

The long-term safety of danazol in women with hereditary angioedema

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Danazol-induced hepatocellular adenoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Danazol-induced hepatocellular adenomas. A case report and review of the literature

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. jean.de.serres@aventis.com

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Misdiagnosis of hereditary angio-oedema type 1 and type 2

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Bradykinin and the pathophysiology of angioedema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Clinical management of hereditary angio-oedema in children.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angioedema with normal C1-inhibitor activity in women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Asphyxiation by laryngeal edema in patients with hereditary angioedema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Successful use of danazol for hereditary angio-oedema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angioneurotic edema: a clinical survey

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Therapy in hereditary angioneurotic oedema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angioneurotic oedema and pregnancy. Case reports and review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Inherited C1 inhibitor deficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angioedema: its diagnostic and management perspectives

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

The C1 inhibitor deficiency. A review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angioneurotic edema. Clinical aspects and extended diagnostic and therapeutic possibilities

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Classification of side-effects to danazol therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Liver damage from long-term methyltestosterone

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angioedema: case report and review of management.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angio-oedema: treatment with danazol. Report of a case

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Regulation of C1 inhibitor synthesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Long-term treatment of C1 inhibitor deficiency with epsilon-aminocaproic acid in two patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hypercholesterolaemia and coronary heart disease: an answer.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Study of an anabolic steroid. Certain effects of oxymetholone on small children

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

30 May 2018

Hereditary Angio-œdema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

C1̅ Inhibitor: Evidence for Decreased Hepatic Synthesis in Hereditary Angioneurotic Edema

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angio-oedema treated with E-aminocaproic acid

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Erythema marginatum preceding hereditary angioedema.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Letter: Liver tumours and steroid hormones.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Androgens and hepatocellular carcinoma.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Age- and sex-specific pediatric reference intervals: study design and methods illustrated by measurement of serum proteins with the Behring LN Nephelometer

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hormonally exacerbated hereditary angioedema

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angioedema: The use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Preliminary experience with danazol in children with precocious puberty

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hepatic function and fibrinolysis in patients with hereditary angioedema undergoing long-term treatment with tranexamic acid.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

The Anesthetic and Perioperative Management of a Patient with Documented Hereditary Angioneurotic Edema

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Reticulate erythema—a prodrome in hereditary angio-oedema

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Hereditary angioneurotic oedema

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Prophylaxis of attacks of hereditary angioedema

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

30 May 2018

Hereditary angiooedema.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with Echinococcus granulosus.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Pathogenetic and clinical aspects of C1 inhibitor deficiency

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02726.X

Post-Traumatic Osteopenia: A Quantitative Study of the Bone Mineral Mass in the Femur Following Fracture of the Tibia in Man Using Americium-241 as a Photon Source

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02726.X

GUIDELINES ON THERAPEUTIC PRODUCTS TO TREAT HAEMOPHILIA AND OTHER HEREDITARY COAGULATION DISORDERS.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Angioneurotic edemas of the upper aerodigestive tract after ACE-inhibitor treatment.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Expression of C1 esterase inhibitor by the baculovirus expression vector system: preparation, purification, and characterization.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Acquired angioedema associated with sinusitis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809312

Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate

28 November 2018

1 reference

12 December 2020

Metabolic effects of danazol

1 reference

12 December 2020

[Contraception and pregnancy in hereditary angioedema]

1 reference

12 December 2020

Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives

1 reference

12 December 2020

Anabolic steroids in hereditary angiooedema

1 reference

12 December 2020

Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications

1 reference

12 December 2020

Hereditary angioedema

1 reference

12 December 2020

Therapy of “the Neurotic Edema”

1 reference

12 December 2020

Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study

1 reference

12 December 2020

Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases

1 reference

12 December 2020

Ambiguous genitalia in a term female infant due to exposure to danazol in utero

1 reference

12 December 2020

Oral manifestations and dental management of patients with hereditary angioedema

1 reference

12 December 2020

Hereditary angioedema: an appraisal of 104 cases

1 reference

12 December 2020

A family study of hereditary angioneurotic oedema

1 reference

12 December 2020

Fresh frozen plasma prophylaxis for hereditary angioedema during pregnancy. A case report

1 reference

12 December 2020

Danazol therapy for hereditary angio-oedema in children

1 reference

12 December 2020

Tranexamic acid: preoperative prophylactic therapy for patients with hereditary angioneurotic edema

1 reference

12 December 2020

Hereditary angioedema with gastrointestinal involvement: endoscopic appearance

1 reference

12 December 2020

Clinical problems in the C1-inhibitor deficient patient

1 reference

12 December 2020

Transient Adrenogenital Syndrome due to Exposure to Danazol in Utero

1 reference

12 December 2020

Hereditary angioedema

1 reference

12 December 2020

Angioedema and oral contraception

1 reference

12 December 2020

Long-term therapy of hereditary angioedema (HAE). Preventive management with fluoxymesterone and oxymetholone in severely affected males and females

1 reference

12 December 2020

Replacement therapy in hereditary and acquired angioedema

1 reference

12 December 2020

Tranexamic Acid Therapy in Hereditary Angioneurotic Edema

1 reference

12 December 2020

Long-term therapy of hereditary angioedema with danazol.

1 reference

12 December 2020

Hereditary angioneurotic oedema in Finland. Clinical, immunological and genealogical studies

1 reference

12 December 2020

Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection

1 reference

12 December 2020

Hereditary angiooedema

1 reference

12 December 2020

Hereditary angioedema: danazol therapy in a 5-year-old child

1 reference

12 December 2020

Hereditary angioedema first apparent in the ninth decade during treatment with ACE inhibitor

1 reference

12 December 2020

Hereditary angio-oedema in children

1 reference

12 December 2020

Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients

1 reference

12 December 2020

Hereditary angio-oedema: treatment with C1 esterase inhibitor concentrate

1 reference

12 December 2020

Molecular genetics of C1 inhibitor

1 reference

12 December 2020

C1 inhibitor and diagnosis of hereditary angioedema in newborns

1 reference

12 December 2020

Hereditary angioneurotic edema of the gastrointestinal tract

1 reference

12 December 2020

Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience

1 reference

12 December 2020

Hereditary angioedema: a decade of management with stanozolol

1 reference

12 December 2020

Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection

1 reference

12 December 2020

Hereditary angioedema

1 reference

12 December 2020

Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients

1 reference

12 December 2020

Hereditary Angioedema: the Clinical Syndrome and Its Management

1 reference

12 December 2020

1 reference

12 December 2020

Cholesterol, High Density Lipoprotein and Danazol

1 reference

12 December 2020

Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor

1 reference

12 December 2020

Hepatitis C and pasteurized C1-inhibitor concentrate

1 reference

12 December 2020

Evaluation of solvent/detergent treated plasma in the management of patients with hereditary and acquired coagulation disorders

1 reference

12 December 2020

The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures

1 reference

12 December 2020

Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

The use of fresh-frozen plasma in hereditary angioedema

1 reference

12 December 2020

Clinical and biochemical effects of stanozolol therapy for hereditary angioedema

1 reference

12 December 2020

Danazol and cholesterol metabolism

1 reference

12 December 2020

Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema

1 reference

12 December 2020

HEREDITARY ANGIO-NEUROTIC ŒDEMA

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02726.X

7 January 2021